A new oncogene that is clearly involved in the pathogenesis of neuroblastoma has been identified by Australian researchers, who say this discovery raises hopes for new therapies. Indeed, a combination ...

Neuroblastoma, an aggressive cancer mainly affecting infants, is seeing advances in treatment options, driving market growth. Immunotherapy, significantly boosting survival rates in high-risk cases, ...

Phase 1 Dose Escalation Underway at Six Leading U.S. Oncology Centers; MYC Overexpression and CDKN2A/B Deletion Identified as ...

Please provide your email address to receive an email when new articles are posted on . Three of four patients with neuroblastoma had stable disease through four or more treatment cycles. Phase 2 is ...

Researchers at Linköping University show how two important cancer-related proteins can be prevented from collaborating with each other.

Researchers at Linköping University show how two important cancer-related proteins can be prevented from collaborating with ...

Childhood neuroblastoma is often a fatal disease. Despite initial treatment success, most patients relapse or develop resistance to the current therapies. A new approach using a combination of two ...

Treatment for high-risk forms of neuroblastoma is effective but can cause serious complications. MSK researchers are investigating using a lower radiation dose to treat this cancer, which occurs in ...

For many decades, neuroblastoma has remained a challenging disease for both clinicians and researchers. Now, techniques that efficiently specify both comprehensive genetic and gene-expression ...

Scientists have discovered gene mutations that are the main cause of the inherited (familial) version of the childhood cancer neuroblastoma. In addition, the researchers found that the same mutations ...

Neuroblastoma is a childhood cancer, most commonly affecting children aged between 2 -3 and can be fatal. Since the tumor cells resemble certain cells in the adrenal glands, a joint research group ...